Discover more insights into Mediated Adverse 중재된 부작용

Keywords frequently search together with Mediated Adverse 중재된 부작용

Narrow sentence examples with built-in keyword filters

Mediated Adverse sentence examples within syndrome toxic epidermal



Controversies in drug allergy: Testing for delayed reactions.


A Computational Platform and Guide for Acceleration of Novel Medicines and Personalized Medicine.

Mediated Adverse sentence examples within Immune Mediated Adverse



Heparin induced thrombocytopenia: A case-based re-appraisal


Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report

Mediated Adverse sentence examples within Immunologically Mediated Adverse



Controversies in drug allergy: Testing for delayed reactions.


Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions


Learn more from Mediated Adverse 중재된 부작용


Mediated Adverse sentence examples within Ige Mediated Adverse



Prevalence of Symptoms of Mast Cell Activation in Patients with Postural Orthostatic Tachycardia Syndrome and Hypermobile Ehlers‐Danlos Syndrome: 555


Omalizumab and Systemic Mastocytosis: A Single Centre Case Series: 554

Mediated Adverse sentence examples within mediated adverse event



Immune-checkpoint inhibitors induced diarrhea and colitis: a review of incidence, pathogenesis and management.


Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion.

Mediated Adverse sentence examples within mediated adverse effect



Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome


Abstract B089: Application of precision cancer immunotherapy design tools to bladder cancer: Non-self-like neoepitopes as a prognostic biomarker

Mediated Adverse sentence examples within mediated adverse reaction



Challenge of immune-mediated adverse reactions in the emergency department


A Computational Platform and Guide for Acceleration of Novel Medicines and Personalized Medicine.

Mediated Adverse sentence examples within mediated adverse drug



Controversies in drug allergy: Testing for delayed reactions.


Acute generalized exanthematous pustulosis/exfoliative dermatitis eruption

Mediated Adverse sentence examples within mediated adverse food



Prevalence of Symptoms of Mast Cell Activation in Patients with Postural Orthostatic Tachycardia Syndrome and Hypermobile Ehlers‐Danlos Syndrome: 555


Omalizumab and Systemic Mastocytosis: A Single Centre Case Series: 554

Mediated Adverse sentence examples within mediated adverse cardiac



NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo.


miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity.


Immune-checkpoint inhibitors induced diarrhea and colitis: a review of incidence, pathogenesis and management.



Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion.



Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment



Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study



Vaccine Allergy? Skin Testing and Challenge at a Tertiary Pediatric Hospital in Melbourne, Australia.



Anti-PD-1immunotherapy in advanced metastatic melanoma: State of the art and future challenges.



Challenge of immune-mediated adverse reactions in the emergency department



Caring for Patients Treated With Checkpoint Inhibitors for the Treatment of Metastatic Merkel Cell Carcinoma.



Pyrazine-Fused Triterpenoids Block the TRPA1 Ion Channel in Vitro and Inhibit TRPA1-Mediated Acute Inflammation in Vivo.



Nicorandil prevents doxorubicin-induced human umbilical vein endothelial cell apoptosis.



Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome



Controversies in drug allergy: Testing for delayed reactions.



[Autoimmune side effects of immune-checkpoint inhibitor therapies in oncology: pathogenesis, clinic and treatment].



Immunotherapy-induced endocrinopathies: assessment, management and monitoring


More Mediated Adverse 중재된 부작용 sentence examples
10.3760/CMA.J.ISSN.1673-4912.2019.05.003

Acute generalized exanthematous pustulosis/exfoliative dermatitis eruption



A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms.



A Computational Platform and Guide for Acceleration of Novel Medicines and Personalized Medicine.



Heparin induced thrombocytopenia: A case-based re-appraisal


More Mediated Adverse 중재된 부작용 sentence examples
10.1158/2326-6074.CRICIMTEATIAACR18-B089

Abstract B089: Application of precision cancer immunotherapy design tools to bladder cancer: Non-self-like neoepitopes as a prognostic biomarker



A case of immune-mediated encephalitis related to daclizumab therapy



BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains.



Prevalence of Symptoms of Mast Cell Activation in Patients with Postural Orthostatic Tachycardia Syndrome and Hypermobile Ehlers‐Danlos Syndrome: 555



Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population



Omalizumab and Systemic Mastocytosis: A Single Centre Case Series: 554



Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy.



Immune‐related adverse reactions in the hepatobiliary system: second‐generation check‐point inhibitors highlight diverse histological changes



ИММУНОТЕРАПИЯ РАКА ЖЕЛУДКА



Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function



FRI0590 UVEITIS SECONDARY TO CHECKPOINT INHIBITORS



Zulassungsstatus und Nebenwirkungen von Immuncheckpointinhibitoren



Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study.



Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H.



Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report



Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors



NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo.



Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine.



Adverse effects of immuno-oncology drugs—Awareness, diagnosis, and management: A literature review of immune-mediated adverse events



Inhibition of nuclear thioredoxin aggregation attenuates PM2.5‐induced NF‐&kgr;B activation and pro‐inflammatory responses



Immune-Mediated Therapies in Lymphoma.



Intractable disseminated maculopapular eruption in a patient with granulocyte macrophage colony‐stimulating factor‐producing anaplastic thyroid carcinoma



Benefit‐risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers



Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs



Is There an Association Between Extreme Levels of Boron Exposure and Decrease in Y:X Sperm Ratio in Men? Results of an Epidemiological Study



Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade



Pembrolizumab-induced CNS vasculitis: Neurologic adverse events due to checkpoint inhibitors


More Mediated Adverse 중재된 부작용 sentence examples
10.1146/annurev-pharmtox-010818-021818

Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.



Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions



The Advanced Practice Provider Perspective: Treating Patients With Immuno-Oncology Combination Therapy Across Tumor Types



Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.



Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata



AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report



Severe arthritis and tenosynovitis caused by immune checkpoint blockade therapy with pembrolizumab (anti-PD-1 antibody)



(R)‐Ketamine exerts antidepressant actions partly via conversion to (2R,6R)‐hydroxynorketamine, while causing adverse effects at sub‐anaesthetic doses



3D‐multi‐spectral T2 mapping near metal implants



FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation.



Immune-related lichenoid mucocutaneous erosions during anti-PD-1 immunotherapy in metastatic renal cell carcinoma - A case report



Defining Regional Differences in Drug‐Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A Tool to Improve Drug Safety?



Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer



Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody.



miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity.



Strategies for Recognizing and Managing Immune-Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors.



Bone Marrow Findings of Immune-Mediated Pure Red Cell Aplasia Following Anti-Programmed Cell Death Receptor-1 Therapy: A Report of Two Cases and Review of Literature



Targeting tumor-resident mast cells for effective anti-melanoma immune responses.



Az onkológiában alkalmazott immuncheckpointgátló terápiák autoimmun mellékhatásai: patogenezis, klinikum és terápia



First Drug Approved for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma.



PM2.5- and PM10-bound polycyclic aromatic hydrocarbons (PAHs) in the residential area near coal-fired power and steelmaking plants of Taichung City, Taiwan: In vitro-based health risk and source identification.



Bee Venom Immunotherapy: Current Status and Future Directions



Drug hypersensitivity in HIV infection.



HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.



Unfractionated heparin induced thrombocytopenia: A case review



Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer



PD-1 Inhibitors: Safety of Use and Management of Immune-Mediated Adverse Reactions in Patients With Head and Neck Cancer.



A case of atezolizumab‐induced photodistributed bullous pemphigoid



PD‐(L)1 inhibitors vs. chemotherapy vs. their combination in front‐line treatment for NSCLC: An indirect comparison



Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring



A case of checkpoint inhibitor-induced celiac disease



Systematic Meta-Analysis Identifies Co-Expressed Kinases and GPCRs in Ovarian Cancer Tissues Revealing a Potential for Targeted Kinase Inhibitor Delivery



Activation of human nuclear receptors by perfluoroalkylated substances (PFAS).



Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma



A Review of Immune-Mediated Adverse Events in Melanoma


Learn more from Mediated Adverse 중재된 부작용

Mediated Adverse 중재된 부작용


Mediated Adverse 중재된 부작용
Encyclopedia 백과사전